J. Safra Sarasin Holding Ag Sarepta Therapeutics, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.76 Trillion
- Q3 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 15,503 shares of SRPT stock, worth $1.71 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,503
Previous 11,456
35.33%
Holding current value
$1.71 Million
Previous $1.81 Billion
6.97%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$991 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$692 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$482 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$472 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...